Deprecated: Optional parameter $page_id declared before required parameter $update_data is implicitly treated as a required parameter in /home/w01c/public_html/assets/includes/functions_two.php on line 1966

Deprecated: Optional parameter $post_id declared before required parameter $update_data is implicitly treated as a required parameter in /home/w01c/public_html/assets/includes/functions_two.php on line 2070

Deprecated: Optional parameter $group_id declared before required parameter $update_data is implicitly treated as a required parameter in /home/w01c/public_html/assets/includes/functions_two.php on line 2741

Deprecated: Optional parameter $lang declared before required parameter $langs is implicitly treated as a required parameter in /home/w01c/public_html/assets/includes/functions_two.php on line 6246
Artificial Insemination Market 2023-28 | Size, Trends, Share, Growth, Forecast

Artificial Insemination Market 2023-28 | Size, Trends, Share, Growth, Forecast

The global artificial insemination market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9.13% during 2023-2028.

IMARC Group, a leading market research company, has recently released a report titled “Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global artificial insemination market demand, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What Are The Growth Prospects Of The Artificial Insemination Industry?

According to the report, The global artificial insemination market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9.13% during 2023-2028.

What is Artificial Insemination?

Artificial insemination refers to an assisted fertilization treatment wherein the sperm is artificially introduced into the cervix and uterus of a female. This procedure is employed through artificial insemination homologous (AIH), artificial insemination donor semen (AID), or intrauterine insemination (IUI). Artificial insemination is beneficial for infertility, old age, poor sperm quality, polycystic ovary syndrome (PCOS), and endometriosis. Other than this, artificial insemination is also adopted in animal breeding to conserve endangered species.

Request for a free sample copy of this report: https://www.imarcgroup.com/artificial-insemination-market/requestsample

What are the growth prospects and trends in the Artificial Insemination industry?

The growing rate of infertility, changing lifestyles, and increasing awareness regarding the availability of alternative reproductive treatments are majorly driving the global artificial insemination market. The legalization of same-sex marriage by governments of various nations is further contributing to the market growth. Moreover, there has been an increase in the adoption of artificial insemination in the breeding of livestock animals as it is considered more hygienic, thereby preventing the spread of zoonotic diseases. This is also supported by the escalating demand for animal-based proteins.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Intrauterine
  • Intracervical
  • Intravaginal
  • Intratubal

Breakup by Source Type:

  • AIH-Husband
  • AID-Donor

Breakup by End Use:

  • Hospitals and Clinics
  • Fertility Centers
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Conceivex Inc.
  • FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
  • Genea Limited
  • Genus plc
  • Hamilton Thorne Inc.
  • Hi-Tech Solutions
  • Kitazato Corporation
  • Pride Angel
  • Rinovum Women’s Health LLC
  • Rocket Medical plc
  • TenderNeeds Fertility LLC
  • Vitrolife AB.

Ask Analyst for Free Sample Report: https://www.imarcgroup.com/request?type=reportid=4023flag=F

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal


Abhay Rajput

30 Blog posts

Comments